What is he best known for?
The fields of study he is best known for:
His primary areas of study are Molecular biology, Cell culture, Messenger RNA, Oligonucleotide and Gene expression.
His studies deal with areas such as Reticulocyte, Oncogene, HeLa, Leukemia and Deoxyribonuclease as well as Molecular biology.
The concepts of his Cell culture study are interwoven with issues in Cancer cell, Biophysics, Cell growth and Intracellular.
His Messenger RNA study improves the overall literature in Gene.
His Gene study incorporates themes from Immunofluorescence and Transferrin receptor.
Oligonucleotide is the subject of his research, which falls under Biochemistry.
His most cited work include:
- A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1 (591 citations)
- Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA (333 citations)
- Oligodeoxynucleoside phosphorothioate stability in subcellular extracts, culture media, sera and cerebrospinal fluid. (191 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Molecular biology, Biochemistry, Oligonucleotide, Cancer research and Messenger RNA.
His research integrates issues of Gene expression, Gene, Peptide nucleic acid, Oncogene and Receptor in his study of Molecular biology.
His Oncogene research focuses on Cancer cell and how it relates to Biophysics, Nanotechnology, Antibody and Carbon nanotube.
As a member of one scientific family, he mostly works in the field of Oligonucleotide, focusing on Stereochemistry and, on occasion, Stereospecificity and Nucleotide.
Eric Wickstrom combines subjects such as Breast cancer and Gene silencing with his study of Cancer research.
His Mutant research extends to the thematically linked field of Messenger RNA.
He most often published in these fields:
- Molecular biology (29.17%)
- Biochemistry (22.22%)
- Oligonucleotide (18.06%)
What were the highlights of his more recent work (between 2010-2020)?
- Breast cancer (8.80%)
- Molecular biology (29.17%)
- Biochemistry (22.22%)
In recent papers he was focusing on the following fields of study:
Eric Wickstrom mainly focuses on Breast cancer, Molecular biology, Biochemistry, Receptor and Cancer.
Eric Wickstrom has included themes like Gene knockdown, RNA, Oligonucleotide, DNA and Messenger RNA in his Molecular biology study.
The subject of his Oligonucleotide research is within the realm of Gene.
His studies in Messenger RNA integrate themes in fields like Mutation and Wild type.
In general Biochemistry, his work in Monoamine oxidase is often linked to Fluorescence microscope, Monoamine neurotransmitter and DAMGO linking many areas of study.
His Receptor research includes elements of Western blot, Peptide and DOTA.
Between 2010 and 2020, his most popular works were:
- Molecular Determinants of Epidermal Growth Factor Binding: A Molecular Dynamics Study (40 citations)
- The metastatic potential of triple-negative breast cancer is decreased via caloric restriction-mediated reduction of the miR-17~92 cluster (28 citations)
- Fluorescence Detection of KRAS2 mRNA Hybridization in Lung Cancer Cells with PNA-Peptides Containing an Internal Thiazole Orange (24 citations)
In his most recent research, the most cited papers focused on:
The scientist’s investigation covers issues in Biochemistry, Molecular biology, microRNA, Breast cancer and Confocal microscopy.
His work on Endocytosis and Receptor as part of general Biochemistry study is frequently connected to Fluorescence microscope and Monoamine neurotransmitter, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His biological study spans a wide range of topics, including RNA, DNA-directed RNA interference, Oligonucleotide, DNA and RNA silencing.
Combinatorial chemistry, Carborane, Gene, Membrane and Sequence is closely connected to Nucleic acid in his research, which is encompassed under the umbrella topic of RNA.
His microRNA research is multidisciplinary, incorporating elements of Tumor suppressor gene, Cancer research, RNA-binding protein and Cell biology.
In his study, Pathology and In vivo is inextricably linked to Gene expression, which falls within the broad field of Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
